TMCnet News
Solarea Bio Announces Licensing Agreement with ADMCAMBRIDGE, Mass., Oct. 19, 2021 /PRNewswire/ -- Solarea Bio, a biotech company based in Cambridge, MA that is developing microbial-based solutions to aid human health, today announced it has signed a technology licensing agreement with global nutrition leader ADM (NYSE: ADM). Global nutrition leader ADM signs microbiome technology licensing agreement with Solarea Bio Solarea Bio has developed innovative technologies to harness the power of microorganisms to modulate inflammatory processes in conditions such as osteoporosis in humans, leveraging the company's extensive capabilities in data science and microbial product development experience. This new agreement allows ADM to examine the functionality and potential for use of these microbes in new food and beverage solutions designed to support health and wellness. "ADM is a well-established and respected partner, and this new agreement will help validate our microbial discovery platform and provide an additional path for Solarea technology to enter the market," said Dr. Gerardo V. Toledo, CEO and co-founder of Solarea Bio, Inc. "The microbiome is one of ADM's six strategic platforms that are powering ADM's growth, and we're continuing to expand our capabilities and develop the next wave of innovation forconsumers who are looking for foods and beverages to support their health and wellness," said Daniel Ramon Vidal, ADM Distinguished Research Fellow in the microbiome field. "We look forward to partnering with Solarea Bio and to leveraging their unique technology and expertise to explore the potential for new nutrition products and solutions." Toledo continued, "The opportunities to create meaningful improvement in people's lives through the commercialization of our technology are vast. We're glad to be moving into the commercial realm and dedicated to finding paths to market that will make the impact that inspires all of us at Solarea." About Solarea About ADM Solarea Media Relations ADM Media Relations View original content to download multimedia:https://www.prnewswire.com/news-releases/solarea-bio-announces-licensing-agreement-with-adm-301403293.html SOURCE Solarea Bio |